A final rule is expected later this spring, and many of its proposed changes would be time‑consuming and costly for covered entities and business associates to manage. But implementing some of these practices and controls could help.

Pharmaceutical manufacturers offer robust patient services programs – with nurse navigators, mobile apps, in-home testing and more – to improve medication adherence. But too many programs still use outdated analytics platforms to parse data.

What makes the New Zealand case worth following is what the investigations are actually testing: Are health systems truly designed to protect highly sensitive information?